Status
Conditions
Treatments
About
All hospitalised patients with COVID-19 who have positive RT-PCR for SARS-COV-2 will be included in the study.
The patients will be divided into two groups, as diabetics and non-diabetics. The COVID-19 patients' medical records will be evaluated and compared in terms of the duration of hospitalization, the presence of lung involvement in Computerised Tomography, the need for intensive care unit and mortality rates in patients with and without diabetes.
Full description
All hospitalised patients with COVID-19 who have positive RT-PCR for SARS-COV-2 will be included in the study.
The patients will be divided into two groups, as diabetics and non-diabetics. The diagnosis of diabetes mellitus will be extracted from the medical records and medical history of the patients hospitalised with COVID-19.
The COVID-19 patients medical records will be evaluated and compared in terms of the duration of hospitalization, the presence of lung involvement in Computerised Tomography, the need for intensive care unit and mortality rates in patients with and without diabetes.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
2,000 participants in 2 patient groups
Loading...
Central trial contact
Cevdet Duran
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal